Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by bilosellhion Apr 27, 2005 8:24pm

128 Views

Post# 8965570

RE: Chief re:3Mill extra cash

https://biz.yahoo.com/prnews/050222/to028_1.html its money from the Feb warrants - they got nadda, zilch, zero in 2005 from their april warrants. next warrant stop is oct 7/05 with about 100K cannacord $7 warrants and about 500K regular $7.50 warrants can thompson make pigs really fly? apparently it was too fat with options in april to get airborne, despite all of bigwin/BIOEYE's pumping and heavy breathing. perhaps its time to send the fat pig to the stockhouse?

Bullboard Posts

Debt-free cannabis company set for next stage of growth